Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis.
Lin, T
Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis. [electronic resource] - International journal of clinical practice Apr 2012 - 399-408 p. digital
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
1742-1241
10.1111/j.1742-1241.2011.02806.x doi
Aged
Aged, 80 and over
Alendronate--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Bone Density--drug effects
Bone Density Conservation Agents--therapeutic use
Denosumab
Drug-Related Side Effects and Adverse Reactions
Female
Humans
Multicenter Studies as Topic
Osteoporosis, Postmenopausal--drug therapy
Randomized Controlled Trials as Topic
Risk Factors
Treatment Outcome
Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis. [electronic resource] - International journal of clinical practice Apr 2012 - 399-408 p. digital
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
1742-1241
10.1111/j.1742-1241.2011.02806.x doi
Aged
Aged, 80 and over
Alendronate--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Bone Density--drug effects
Bone Density Conservation Agents--therapeutic use
Denosumab
Drug-Related Side Effects and Adverse Reactions
Female
Humans
Multicenter Studies as Topic
Osteoporosis, Postmenopausal--drug therapy
Randomized Controlled Trials as Topic
Risk Factors
Treatment Outcome